Drug Benefit Solutions is an educational platform explaining how pharmacy benefit managers (PBMs) reduce costs and improve quality on prescription drug benefits for consumers, employers, unions, and government programs.
Drug Benefit Solutions is a project of the Pharmaceutical Care Management Association (PCMA).
Market Watch: Mylan offers price plan to help patients but its programs are still short on details
August 26, 2016
Pharmaceutical companies have not routinely fully disclosed how these patient assistance programs work and are funded in their financial statement...
PCMA President Mark Merritt says blaming payers for these massive price hikes is a red herring
August 25, 2016
“Blaming payers for these massive price hikes is a red herring and doesn’t pass the laugh test with policymakers,” Mark...
Pittsburgh Post-Gazette: Mylan offers new discounts for its EpiPen
August 25, 2016
Outrage over escalating prices for Mylan’s EpiPen forced the company to react Thursday, as lawmakers demanded relief for parents with...
Pittsburgh Tribune-Review: Mylan to expand discount programs as EpiPen prices spike
August 25, 2016
“It’s not credible to assert that Mylan’s price hikes are the fault of those paying the bills: namely the employers,...
CNN: EpiPen CEO: Blame the ‘broken’ system, not me
August 25, 2016
Mylan was forced to respond to the national outrage over a more than 400% increase in price for the lifesaving allergy...
USA Today: PCMA President Mark Merritt Shines Light on Drug Manufacturer Copay Coupon Programs
June 08, 2016
Charity-run funds to help patients pay high co-payments face new scrutiny by prosecutors in two states and increased federal oversight,...
Pharmaceutical Commerce: PCMA President Mark Merritt Discusses Drug Prices, other Key Issues
May 10, 2016
As befits the sizable part of the US economy that healthcare represents, its major sectors—hospital providers, insurers, medical professional societies...
Pharmaceutical Commerce: PCMA President Mark Merritt Discusses Drug Prices, other Key Issues
May 10, 2016
As befits the sizable part of the US economy that healthcare represents, its major sectors—hospital providers, insurers, medical professional societies...
April 18, 2016
After joining a Medicare Part D prescription drug plan recently, I was happy to see that one of its member...
PCMA President Mark Merritt: Drugstore Lobby Agenda will Raise Rx Costs
March 25, 2016
As policymakers explore ways to reduce prescription drug costs, the independent drugstore lobby wants to pass legislation, H.R. 244, that...
January 24, 2016
Prescription-drug abuse in Florida and nationwide is a serious problem that deserves real solutions....
Bloomberg: How Valeant Tripled Prices, Doubled Sales of Flatlining Drug
January 08, 2016
No wonder investors once loved Michael Pearson. In short order, he managed to double sales of Wellbutrin XL, the popular...